Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05389787 · ClinicalTrials.gov registry record · NA

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

A NA study of Schizophrenia and Condition, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05389787 is a NA study of Schizophrenia and Condition that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 40 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05389787, a NA study of Schizophrenia and Condition, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a single-site, sham-controlled, randomized trial in a total of 40 subjects between ages 18 and 60 years with schizophrenia. This study will investigate the effects of 4-week rTMS treatment on brain and cognitive functions in patients. Subjects will be randomized to one of the following arms: Arm 1: Standard of Care (SOC) and active rTMS Arm 2: Standard of Care (SOC) and sham rTMS Each participant will receive rTMS five days per week, for four consecutive weeks. Functional magnetic resonance imaging (fMRI) scans, clinical assessments, and cognitive tests will be performed at baseline, end of the 2nd week, and end of the 4th week.

Conditions Studied

Schizophrenia Condition Cerebellar Function

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

New York

  • Zucker Hillside Hospital - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-08-18
Est. Completion 2027-08-31
Phase NA

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05389787

The ClinicalTrials.gov registry entry for NCT05389787 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (82% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT05389787 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05389787 about?

NCT05389787 is a clinical study titled "Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study". This is a single-site, sham-controlled, randomized trial in a total of 40 subjects between ages 18 and 60 years with schizophrenia. This study will investigate the effects of 4-week rTMS treatment on brain and cognitive functions in patients. Subjects will be randomized to one of the following arms:...

What is the current status of trial NCT05389787?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-08-18. Estimated completion is 2027-08-31.

What conditions does trial NCT05389787 study?

This clinical trial studies the following conditions: Schizophrenia, Condition, Cerebellar Function.

What interventions are being tested in trial NCT05389787?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05389787?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05389787 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Condition

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.